PREVALENCE, PREDISPOSING FACTORS, AND PATHOGENETIC ASPECTS OF ULCERATIVE COLITIS
DOI:
https://doi.org/10.55640/Keywords:
Ulcerative colitis, pseudopolyps, E. coli, genetic factors.Abstract
This article is devoted to a literature review on the etiopathogenetic aspects of ulcerative colitis. The prevalence of ulcerative colitis ranges from 21 to 268 cases per 100,000 population. The annual increase in incidence is 5-20 cases (per 100,000 population), and this figure continues to grow (approximately 6 times over the past 40 years). Significant factors in the genesis of ulcerative colitis include the use of non-steroidal anti-inflammatory drugs, oral contraceptives, high hygiene standards in childhood, lactose intolerance, consumption of large amounts of refined carbohydrates, and the potential role of artificial feeding and psychological stress. It is known that appendectomy at a young age has a protective effect against the development of ulcerative colitis.
Downloads
References
1.Cardona-Castro N., Sánchez-Jiménez M., Rojas W. IL-10 gene promoter polymorphisms and leprosy in a Colombian population sample. Biomedica, 2012, vol. 32, pp. 71–76. Available at: http://www.scielo.org.co/scielo. php?script=sci_arttext&pid=S0120–41572012000100009&lng=en&nrm=iso&tlng=en, accessed 17.10.2015.
2.Hyun M.H., Lee C.H., Kang M.H. Interleukin-10 Promoter Gene Polymorphisms and Susceptibility to Asthma: a Meta-Analysis. PLoS One, 2013, vol. 8, iss. 1, pp. 1–8.
3.Inagaki Y. Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers / Y. Inagaki, H. Xu, M. Nakata [et al.] // Biosci. Trends. - 2009. Vol. 3(6). P.220-232.
4.Konenkov V.I., Smol’nikova M.V. Strukturnye osnovy i funkcional’naya znachimost’ allel’nogo polimorfizma genov tsitokinov cheloveka i ikh receptorov [The structural basis and functional significance of allelic polymorphism of cytokine genes and their receptors of human]. Medicinskaya immunologiya [Medical immunology], 2013, vol. 5, no. 1-2, pp. 11–28. (In Russ.).
5.Kyo Y. Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae / Y. Kyo, K. Kato, Y.S. Park [et al.] // Am. J. Respir. Cell. Mol. Biol. - 2012. Vol. 46(2). P.149-156.
6.Mc Guckin M. A. Intestinal barrier dysfunction in inflammatory bowel diseases / M. A. Mc Guckin, R. Eri, L. A. Simms [et al.] // Inflam. Bowel Dis. – 2009. - №15. – P. 100 – 113.
7.McAuley J. L. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection / J. L. McAuley, S. K. Linden, C. W. Ping [et al.] // J. Clin. Invest. - 2007. Vol. 117(8) P 2313–2324.
8.McGuckin M. A. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis / M. A. McGuckin, A. L. Every, C. D. Skene [et al.] // Gastroenterology. - 2007. Vol. 133(4). P.1210–1218.
9.Romero-Valdovinos M., Gudiño-Ramírez A., Reyes-Gordillo J. Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome. Molecular Biology Reports, 2022, vol. 39, iss. 9, pp. 8837–8843.
10.Rubin B.K. Mucus and mucins // B.K. Rubin Otolaryngol. Clin. North. Am. - 2010. - Vol. 43,(1). - P.27-34.
11.Stashkevich D.S., Burmistrova A.L., Ivanova E.L., Timofeeva S.V., Sorokin A.V., Shamurova Yu.Yu. Associaciya polimorfizma promotornoy oblasti gena IL-10 s predraspolozhennost’yu k sindromu razdrazhennogo kishechnika u russkikh Chelyabinskoy oblasti [The Association of polymorphism of the promoter region of the gene of IL-10 with a predisposition to irritable bowel syndrome Russian Chelyabinsk region]. Vestnik Ural’skoy medicinskoy akademicheskoy nauki [Bulletin of the Ural Medical Academic Science], 2022, no. 4 (41), pp. 245– 246. (In Russ.).
12.Tedde A., Putignano L.A., Bagnoli S., Congregati C., Milla M., Sorbi S., Genuardi, L. M. PapiInterleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scandinavian Journal of Gastroenterology, 2018, vol. 43, iss. 6, pp. 712–718. Doi: 10.1080/00365520701885507.
13.Ueno K. MUC1 mucin is a negative regulator of toll-like receptor signaling / K. Ueno, T. Koga, K. Kato [et al.] // Am. J. Respir. Cell. Mol. Biol. - 2008. Vol. 38(3). P.263–268.
14.Williams O.W. Airway mucus: From production to secretion / O. W. Williams, A. Sharafkhaneh, V. Kim [et al.] // Am. J. Respir. Cell Mol. Biol. - 2006. - Vol.34 (5). - P.527-536.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India